SAN DIEGO -- Ionian Technologies, Inc., has received a $665,000 grant from the Bill & Melinda Gates Foundation to develop rapid, point-of-care diagnostic tests for the developing world, using Ionian's proprietary isothermal technology, termed the NEAR Assay.
The study, titled "Rapid Nucleic Acid Diagnostics for Chlamydia, Gonorrhea, and Tuberculosis for Use in the Developing World," will assess the challenges arising from the lack of adequate diagnostic tests in developing countries. Every year, millions of people worldwide suffer from infectious diseases, including tuberculosis, chlamydia, and gonorrhea, particularly in the developing world. The development of rapid, specific, and sensitive diagnostics suitable for use in a point-of-care setting would be an important global health development.
To read the full press release, visit the Ionian Technologies web site.